Nicotine Chitosan Nanoparticles for Sustained Release Intranasal Delivery: Development, Evaluation and Pharmacokinetics Studies
Open Access
- 12 January 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (2) , 114
Abstract
No abstract availableKeywords
Funding Information
- Universiti Teknologi MARA
This publication has 96 references indexed in Scilit:
- Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human StudyNeurology and Therapy, 2022
- The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation ModelJournal of General Internal Medicine, 2022
- The Fourier transform infrared spectroscopy (FTIR) analysis for the clay mineralogy studies in a clastic reservoirJournal of Petroleum Exploration and Production Technology, 2022
- Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal AdministrationClinical Pharmacokinetics, 2020
- Guidelines for cell viability assaysFood Frontiers, 2020
- Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?Pharmaceutical Research, 2019
- Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung DiseaseJAMA Network Open, 2018
- Nicotine replacement therapy versus control for smoking cessationCochrane Database of Systematic Reviews, 2018
- Dynamic light scattering: a practical guide and applications in biomedical sciencesBiophysical Reviews, 2016
- Preparation and properties of ionically cross‐linked chitosan nanoparticlesPolymers for Advanced Technologies, 2008